SUMO2 and cancer: Besides, pro-tumourigenic cancer stem cells (Fig. 2B, Additional file 4: Table S23), the tumour-promoting aberrant immune cells such as microglia and monocyte-derived macrophages [38], were also identified to express high levels of SUMO2 (Additional file 5: Figure S7 and Additional file 4: Table S24).